Literature DB >> 1795400

Involvement of mature tau isoforms in the stabilization of neurites in PC12 cells.

R Hanemaaijer1, I Ginzburg.   

Abstract

Tau microtubule-associated proteins are believed to play a role in regulation of the growth of neuronal processes. In order to study the function of tau protein in vivo, we examined the inhibition of tau expression in PC12 cells by exposing the cells to tau antisense oligodeoxynucleotides. A specific retraction of neurites was observed after 3-4 days of incubation with nerve growth factor (NGF) and the antisense oligodeoxynucleotides. This is different from the previously described retraction of neurites at the initiation step following exposure to tubulin antisense oligodeoxynucleotides, indicating that tau proteins are involved at later stages of neurite outgrowth. Analysis of tau protein isoforms in NGF-induced PC12 cells showed a transition from immature to mature tau isoforms, thus relating the appearance of the latter with the stabilization step of neurite outgrowth. Use of an RNase-protection assay demonstrated a similar switch from immature to mature tau mRNA species. The transition to stable microtubules was verified by the appearance of microtubule bundles and their stability to colchicine treatment. Both phenomena occurred between 2 and 4 days of NGF induction. These results indicate that in vivo only mature tau isoforms are involved in the transition from unstable to stable neurites, which is a key step in neuronal development.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1795400     DOI: 10.1002/jnr.490300117

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  18 in total

1.  Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells.

Authors:  G E Aranda-Abreu; L Behar; S Chung; H Furneaux; I Ginzburg
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

Review 2.  Tau protein function in axonal formation.

Authors:  G Paglini; L Peris; F Mascotti; S Quiroga; A Caceres
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

3.  Tau is enriched on dynamic microtubules in the distal region of growing axons.

Authors:  M M Black; T Slaughter; S Moshiach; M Obrocka; I Fischer
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

4.  Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner.

Authors:  M Kempf; A Clement; A Faissner; G Lee; R Brandt
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

Review 5.  Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration.

Authors:  J Nunez; I Fischer
Journal:  J Mol Neurosci       Date:  1997-06       Impact factor: 3.444

6.  Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly.

Authors:  B L Goode; P E Denis; D Panda; M J Radeke; H P Miller; L Wilson; S C Feinstein
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

7.  Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration.

Authors:  M Pizzi; A Valerio; V Arrighi; M Belloni; A Alberici; P F Spano; M Memo
Journal:  Cell Mol Neurobiol       Date:  1994-10       Impact factor: 5.046

8.  Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding.

Authors:  Chad J Leugers; Gloria Lee
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

9.  Respective roles of neurofilaments, microtubules, MAP1B, and tau in neurite outgrowth and stabilization.

Authors:  T B Shea; M L Beermann
Journal:  Mol Biol Cell       Date:  1994-08       Impact factor: 4.138

10.  Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization.

Authors:  Yasmine S Touil; Arlette Fellous; Daniel Scherman; Guy G Chabot
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.